美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Inspire Corporate Bond ETF

24.18

-0.0700-0.29%

盘后：24.180.00000.00%19:00 EST

成交量：5.49万

成交额：132.87万

市值：4.79亿

市盈率：- -

高：24.23

开：24.23

低：24.15

收：24.25

52周最高：24.85

52周最低：22.84

股本：1,980.00万

流通股本：1,980.00万

量比：0.82

换手率：0.28%

股息：1.01

股息率：4.17%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

释放pipeline in a drug潜力 NLRP3能否催生下一个“药王”?

智通财经网

Vivosim Labs, Inc.盘中异动大幅下跌8.35%

60亿美元豪赌见效！武田自免口服新药针对中重度斑块状银屑病3期数据积极，拟明年向FDA提交上市申请

中信证券：新老管线数据读出频现 MNC加速IBD领域布局

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IBD"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBD\",,,,,undefined,":{"symbol":"IBD","market":"US","secType":"STK","nameCN":"Inspire Corporate Bond ETF","latestPrice":24.18,"timestamp":1770670800000,"preClose":24.25,"halted":0,"volume":54948,"hourTrading":{"tag":"盘后","latestPrice":24.18,"preClose":24.18,"latestTime":"19:00 EST","volume":14,"amount":338.78,"timestamp":1770681616816,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0028865979381443416,"floatShares":19800000,"shares":19800000,"eps":0,"marketStatus":"已收盘","change":-0.07,"latestTime":"02-09 16:00:00 EST","open":24.23,"high":24.23,"low":24.15,"amount":1328702.363784,"amplitude":0.003299,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":24.25,"sharesOutstanding":19800000,"nav":24.13,"aum":477872152.99,"dividendRate":0.041745,"bidAskSpread":0.001804,"preHourTrading":{"tag":"盘前","latestPrice":22.18,"preClose":24.25,"latestTime":"08:00 EST","volume":1,"amount":22.18,"timestamp":1770642005573,"change":-2.07,"changeRate":-0.085361,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":24.18,"preClose":24.18,"latestTime":"19:00 EST","volume":14,"amount":338.78,"timestamp":1770681616816,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.824389},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBD\",,,,,undefined,":{"symbol":"IBD","floatShares":19800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.824389,"shares":19800000,"dividePrice":1.0094,"high":24.23,"amplitude":0.003299,"preClose":24.25,"low":24.15,"week52Low":22.84,"pbRate":"--","week52High":24.85,"institutionHeld":0,"latestPrice":24.18,"eps":0,"divideRate":0.041745,"volume":54948,"delay":0,"ttmEps":0,"open":24.23,"prevYearClose":24.2,"prevWeekClose":24.25,"prevMonthClose":24.15,"prevQuarterClose":24.2,"fiveDayClose":24.09,"twentyDayClose":24.12,"sixtyDayClose":24.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBD\",params:#limit:5,,,undefined,":[{"date":"2026-01-27","symbol":"IBD","amount":0.0592,"announcedDate":"2026-01-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-27","defaultRemindTime":1769524200000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-02","payableDate":"2026-01-27","currency":"USD","dateTimestamp":1769490000000,"payDate":"2026-02-02"},{"date":"2025-12-17","symbol":"IBD","amount":0.121,"announcedDate":"2025-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-17","defaultRemindTime":1765981800000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-17","currency":"USD","dateTimestamp":1765947600000,"payDate":"2025-12-24"},{"date":"2025-11-21","symbol":"IBD","amount":0.0729,"announcedDate":"2025-11-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-21","defaultRemindTime":1763735400000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-26","payableDate":"2025-11-21","currency":"USD","dateTimestamp":1763701200000,"payDate":"2025-11-26"},{"date":"2025-10-28","symbol":"IBD","amount":0.0824,"announcedDate":"2025-10-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-28","defaultRemindTime":1761658200000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-03","payableDate":"2025-10-28","currency":"USD","dateTimestamp":1761624000000,"payDate":"2025-11-03"},{"date":"2025-09-26","symbol":"IBD","amount":0.0899,"announcedDate":"2025-09-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-26","defaultRemindTime":1758893400000,"name":"Inspire Corporate Bond ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-01","payableDate":"2025-09-26","currency":"USD","dateTimestamp":1758859200000,"payDate":"2025-10-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBD\",market:\"US\",,,undefined,":[{"executeDate":"2017-08-16","recordDate":"2017-08-18","paymentDate":"2017-08-23","value":0.0405,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-25","value":0.0292,"currency":"USD"},{"executeDate":"2017-10-16","recordDate":"2017-10-17","paymentDate":"2017-10-23","value":0.0347,"currency":"USD"},{"executeDate":"2017-11-16","recordDate":"2017-11-17","paymentDate":"2017-11-28","value":0.0389,"currency":"USD"},{"executeDate":"2018-01-29","recordDate":"2018-01-30","paymentDate":"2018-02-05","value":0.0269,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBD\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBD\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609432256","title":"释放pipeline in a drug潜力 NLRP3能否催生下一个“药王”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2609432256","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609432256?lang=zh_cn&edition=fundamental","pubTime":"2026-02-05 16:35","pubTimestamp":1770280559,"startTime":"0","endTime":"0","summary":"近期，英硅智能(03696)宣布提名靶向NLRP3的外周限制性抑制剂ISM5059，该候选药物具有新颖母核，由英硅智能自有Pharma.AI平台驱动设计。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4132","BK4135","LU1169590202.USD","PD","AD","BBB","IBD","CNS","LU1169589451.USD","BK4023"],"gpt_icon":0},{"id":"2602122803","title":"Vivosim Labs, Inc.盘中异动 大幅下跌8.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602122803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602122803?lang=zh_cn&edition=fundamental","pubTime":"2026-01-09 01:55","pubTimestamp":1767894943,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日01时55分，Vivosim Labs, Inc.股票出现异动，股价大幅下挫8.35%。Vivosim Labs, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。Vivosim Labs, Inc.公司简介：VivoSim Labs Inc前身为Organovo Holdings Inc，是一家生物技术公司，专注于开发FXR314治疗炎症性肠病，包括溃疡性结肠炎，基于三维人体组织的临床前景证明以及临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109015545a4acf44f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109015545a4acf44f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VIVS","IBD"],"gpt_icon":0},{"id":"2592755154","title":"60亿美元豪赌见效！武田自免口服新药针对中重度斑块状银屑病3期数据积极，拟明年向FDA提交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2592755154","media":"蓝鲸财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592755154?lang=zh_cn&edition=fundamental","pubTime":"2025-12-19 16:36","pubTimestamp":1766133370,"startTime":"0","endTime":"0","summary":"近日，武田宣布其针对中重度斑块状银屑病成人患者的新一代、高选择性口服酪氨酸激酶2抑制剂Zasocitinib在两项关键性3期、随机、多中心、双盲、安慰剂与活性对照研究中取得积极的主要结果。据悉，武田制药计划在即将举行的医学会议上公布研究数据，并计划自2026财年向美国食品药品监督管理局及其他监管机构递交新药上市申请。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1766128980838994392","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IBD","BMS"],"gpt_icon":0},{"id":"2590550876","title":"中信证券：新老管线数据读出频现 MNC加速IBD领域布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2590550876","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590550876?lang=zh_cn&edition=fundamental","pubTime":"2025-12-11 09:34","pubTimestamp":1765416866,"startTime":"0","endTime":"0","summary":"MNC加速IBD领域布局，中国创新药企业在差异化赛道崭露头角。MNC加速IBD领域布局，中国创新药企业在差异化赛道崭露头角作为自身免疫疾病领域中，患者人数众多且当前一年维持期疗效仍仅有30%-50%临床缓解率的适应症，IBD吸引了众多MNC布局。根据过往交易规模以及MNC对产品峰值的预期，该行预计一项临床阶段的优质IBD资产的交易对价在20亿美金以上。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380203.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064131003.USD","600030","LU1997244956.HKD","LU0405327148.USD","LU2289578879.USD","LU2148510915.USD","LU1328615791.USD","BK1516","LU1655091616.SGD","LU0405327494.USD","06030","LU1255011170.USD","LU1794554557.SGD","BK0196","LU1997245177.USD","BK1147","LU1720050803.USD","BK0188","BK0012","BK1564","BK0028","LU2495084118.USD","BK0183","LU1997245094.SGD","IBD","BK1521","BK0276","LU1064130708.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IBD\",params:#limit:6,delay:false,,,undefined,":[]}}